Browsing Centre for Biochemical Pharmacology by Author "Zangrilli, JG"
Now showing items 1-1 of 1
-
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison, TW; Chanez, P; Menzella, F; Canonica, GW; Louis, R; Cosio, BG; Lugogo, NL; Mohan, A; Burden, A; McDermott, L (Elsevier, 2020-12-22)BACKGROUND: ANDHI was done to assess the efficacy of benralizumab, including onset of effect and impact on health-related quality of life (HRQOL), exacerbation rate, lung function, and nasal polyposis symptoms. METHODS: ...